SAGA Diagnostics has commercially launched its Pathlight test in the US to detect residual disease and recurrence. Comprising ...

New York, July 10, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection ...

How the presence of MRD is associated with disease-free survival (DFS) As we have seen before in previous analysis 1 and in the recently published data, Signatera-positivity after surgery was ...

“Plasma-based, tumor-informed MRD analysis may predict disease recurrence during adjuvant treatment and during posttreatment follow-up,” the authors write. “MRD monitoring may inform ...

MRD assessment using ctDNA can be divided into ... This unique combination empowers reliable longitudinal therapy response analysis, including variant tracking and proactive monitoring, resistance ...

MRD status was assessed at predefined time points (mid-induction [MI], end of induction [EOI], and at 4-6 monthly intervals during maintenance and follow-up). Patients with evaluable biomarker data at ...

It should be noted that only a few of the company's trial sites had the capacity to perform MRD analysis on these patients. Furthermore, 52% of frontline and 31% of R/R AML patients proceeded to ...